XTL Biopharmaceuticals Ltd (XTLB) — Net Asset Quality Index
XTL Biopharmaceuticals Ltd (XTLB) has a Net Asset Quality Index of 63.6% as of December 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA8.55 Million minus total liabilities of ILA3.12 Million yields net assets of ILA5.43 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check XTLB financial resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
XTL Biopharmaceuticals Ltd Net Asset Quality Index Over Time (2013–2024)
This chart shows how XTL Biopharmaceuticals Ltd's Net Asset Quality Index has evolved across 12 annual periods from 2013 to 2024. As of December 2024, the index stands at 63.6%, representing net assets of ILA5.43 Million against total assets of ILA8.55 Million ILA. See XTLB working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for XTL Biopharmaceuticals Ltd (2013–2024)
The table below presents the year-by-year Net Asset Quality Index for XTL Biopharmaceuticals Ltd from 2013 to 2024, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see XTLB market cap overview.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 63.6% | ILA5.43 Million | ILA8.55 Million | ILA3.12 Million | ▼ -27.9 pp |
| 2023 | 91.5% | ILA2.22 Million | ILA2.43 Million | ILA206.00K | ▼ -4.0 pp |
| 2022 | 95.5% | ILA4.00 Million | ILA4.19 Million | ILA187.00K | ▲ +14.9 pp |
| 2021 | 80.6% | ILA5.33 Million | ILA6.62 Million | ILA1.28 Million | ▼ -15.5 pp |
| 2020 | 96.1% | ILA6.25 Million | ILA6.50 Million | ILA254.00K | ▼ -0.7 pp |
| 2019 | 96.8% | ILA6.98 Million | ILA7.21 Million | ILA232.00K | ▼ -0.3 pp |
| 2018 | 97.0% | ILA8.32 Million | ILA8.57 Million | ILA253.00K | ▲ +42.1 pp |
| 2017 | 54.9% | ILA3.62 Million | ILA6.59 Million | ILA2.97 Million | ▼ -34.1 pp |
| 2016 | 89.1% | ILA2.69 Million | ILA3.02 Million | ILA330.00K | ▼ -2.7 pp |
| 2015 | 91.8% | ILA4.89 Million | ILA5.32 Million | ILA436.00K | ▲ +8.9 pp |
| 2014 | 82.9% | ILA4.68 Million | ILA5.64 Million | ILA965.00K | ▼ -1.8 pp |
| 2013 | 84.7% | ILA6.79 Million | ILA8.02 Million | ILA1.23 Million | — |